DaVita Inc. (NYSE:DVA) Shares Sold by Bryn Mawr Capital Management LLC

Bryn Mawr Capital Management LLC trimmed its position in DaVita Inc. (NYSE:DVA) by 61.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,340 shares of the company’s stock after selling 2,160 shares during the period. Bryn Mawr Capital Management LLC’s holdings in DaVita were worth $200,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Convergence Investment Partners LLC grew its position in DaVita by 33.2% during the 4th quarter. Convergence Investment Partners LLC now owns 11,389 shares of the company’s stock worth $1,703,000 after purchasing an additional 2,836 shares during the period. Kentucky Retirement Systems Insurance Trust Fund grew its position in DaVita by 357.7% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 6,252 shares of the company’s stock worth $935,000 after purchasing an additional 4,886 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in DaVita during the 4th quarter worth about $597,000. Venturi Wealth Management LLC grew its position in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the period. Finally, CIBC Asset Management Inc grew its position in DaVita by 1.4% during the 4th quarter. CIBC Asset Management Inc now owns 7,730 shares of the company’s stock worth $1,156,000 after purchasing an additional 109 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $162.80.

DaVita Trading Down 2.5 %

DVA stock opened at $142.33 on Friday. The company’s 50-day simple moving average is $161.03 and its 200-day simple moving average is $157.86. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52-week low of $120.78 and a 52-week high of $179.60. The firm has a market cap of $11.39 billion, a P/E ratio of 13.25, a PEG ratio of 1.14 and a beta of 0.94.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.